NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.71% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.81% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 3.20% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.16% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.89% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.76% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.70% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| UCB | UCB SA | Healthcare | Biotechnology | 2.49% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.45% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.28% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.09% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.02% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.00% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 1.99% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.96% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |